Question to the Foreign, Commonwealth & Development Office:

To ask the Secretary of State for Foreign, Commonwealth and Development Affairs, pursuant to the Answer of 24 April 2023 to Question 181199 on Development Aid: Genito-urinary Medicine, whether his Department has considered the potential merits of monitoring the (a) level of (i) complications and (ii) mortality during (A) abortion and (B) childbirth, (b) quality of aftercare for women following (1) abortion and (2) childbirth and (c) other outcomes associated with services (x) partly and (y) wholly funded from sexual and reproductive health rights funds.

The UK is proud to defend and promote universal and comprehensive sexual and reproductive health and rights (SRHR), including safe abortion and maternal healthcare. The UK uses sexual and reproductive health funds to support services in a range of ways including technical assistance, funding drugs and supplies and delivering services directly, working through NGOs, governments and UN agencies. Examples include the United Nations Population Fund (UNFPA) Supplies Partnership programme and the Global Financing Facility. The risk of complications without these services in place is extremely high. The UK monitors the work of our partners through annual reviews that assess progress against a set of indicators but also assess risk. Information on the monitoring of each of the UK's SRHR programmes can be found on DevTracker.